X. Wang

Improved progression free survival (PFS), and rapid, sustained decrease in tumor perfusion among patients with advanced carcinoid treated with bevacizumab

J. C. Yao, Chaan S. Ng, P. M. Hoff et al. · Journal of Clinical Oncology · 2005 · 57 citations

Medicine, Oncology, Pharmacology +17

Optical Clearing Delivers Ultrasensitive Hyperspectral Dark-Field Imaging for Single-Cell Evaluation

Yi Cui, X. Wang, Wen Ren et al. · ACS Nano · 2016 · 56 citations

Engineering, Biomedical Engineering, Cell Biology +15

Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours

Amado J. Zurita, Mehrdad Khajavi, H-K Wu et al. · British Journal of Cancer · 2015 · 49 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small cell lung cancer: CALGB 30407

Ramaswamy Govindan, Jeffrey A. Bogart, X. Wang et al. · Journal of Clinical Oncology · 2009 · 43 citations

Medicine, Oncology, Radiation Oncology +16

A single-arm, multicenter, phase II trial of osimertinib in patients with epidermal growth factor receptor exon 18 G719X, exon 20 S768I, or exon 21 L861Q mutations

L. Villaruz, X. Wang, Erin M. Bertino et al. · ESMO Open · 2023 · 26 citations · Full text

Medicine, Molecular Medicine, Pharmacotherapy +8